Mills? syndrome: Reporting the disease course with a monthly intravenous immunoglobulin program

被引:1
|
作者
Algahtani, Hussein [1 ,2 ,3 ]
Shirah, Bader [2 ,3 ]
Algahtani, Sarah [4 ]
Attar, Ahmed [1 ]
Abuzinadah, Ahmad R. [5 ,6 ]
机构
[1] King Abdul Aziz Med City, Jeddah, Saudi Arabia
[2] King Saud bin Abdulaziz Univ Hlth Sci, Jeddah, Saudi Arabia
[3] King Abdullah Int Med Res Ctr, Jeddah, Saudi Arabia
[4] Ibn Sina Natl Coll, Jeddah, Saudi Arabia
[5] King Abdulaziz Univ, Coll Med, Internal Med Dept, Neurol Div, Jeddah, Saudi Arabia
[6] King Abdulaziz Univ, King Abdulaziz Univ Hosp, Jeddah, Saudi Arabia
关键词
Mills? syndrome; Intravenous immunoglobulin; Motor neuron disease; Saudi Arabia; LATERAL-SCLEROSIS; HEMIPLEGIA;
D O I
10.1016/j.jneuroim.2021.577562
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mills? syndrome is an extremely rare, slowly progressive, unilateral ascending or descending clinical syndrome of upper motor neuron?predominant hemiparesis. In this article, we describe a case of a middle-aged woman (initial presentation and three years follow-up) who presented with progressive ascending hemiparesis with clinically isolated upper motor neuron signs and normal sensory examination. The patient received monthly intravenous immunoglobulin (IVIG) for three years with no progression of her weakness. To our best knowledge, the response of Mills? syndrome to such an IVIG program has not been reported in the literature so far. We aim to document the clinical response to IVIG in such rare syndrome.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Treatment effects of monthly intravenous immunoglobulin on patients with relapsing - remitting multiple sclerosis: Further analyses of the Austrian immunoglobulin in MS study
    Fazekas, F
    Deisenhammer, F
    StrasserFuchs, S
    Nahler, G
    Mamoli, B
    MULTIPLE SCLEROSIS JOURNAL, 1997, 3 (02) : 137 - 141
  • [22] Efficacy of intravenous immunoglobulin in shrinking lung syndrome associated with mixed connective tissue disease: a case report
    Silverio-Antonio, M.
    Khmelinskii, N.
    Fonseca, J. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (05) : S116 - S117
  • [23] What dose of intravenous immunoglobulin should be administered in Kawasaki disease with suspected systemic capillary leak syndrome?
    Park, Se Jin
    Pai, Ki Soo
    Kim, Ji Hong
    Shin, Jae Il
    EUROPEAN JOURNAL OF PEDIATRICS, 2012, 171 (01) : 203 - 204
  • [25] THE MECHANISM OF EFFICACY OF INTRAVENOUS IMMUNOGLOBULIN IN KAWASAKI-DISEASE
    KANEKO, K
    SAVAGE, COS
    POTTINGER, BE
    SHAH, V
    PEARSON, JD
    DILLON, MJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (11) : 1022 - 1023
  • [26] Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children
    Wu, Shu
    Liao, Ying
    Sun, Yan
    Zhang, Chun-Yu
    Zhang, Qing-You
    Yan, Hui
    Qi, Jian-Guang
    Liu, Xue-Qin
    Chen, Yong-Hong
    Wang, Yu-Li
    Li, Xue-Ying
    Jin, Hong-Fang
    Du, Jun-Bao
    WORLD JOURNAL OF PEDIATRICS, 2020, 16 (06) : 607 - 613
  • [27] Practical approach to the use of intravenous immunoglobulin in neurological disease
    Wills, AJ
    Unsworth, DJ
    EUROPEAN NEUROLOGY, 1998, 39 (01) : 3 - 8
  • [28] Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children
    Shu Wu
    Ying Liao
    Yan Sun
    Chun-Yu Zhang
    Qing-You Zhang
    Hui Yan
    Jian-Guang Qi
    Xue-Qin Liu
    Yong-Hong Chen
    Yu-Li Wang
    Xue-Ying Li
    Hong-Fang Jin
    Jun-Bao Du
    World Journal of Pediatrics, 2020, 16 : 607 - 613
  • [29] Intravenous immunoglobulin and Alzheimer's disease: what now?
    Loeffler, David A.
    JOURNAL OF NEUROINFLAMMATION, 2013, 10
  • [30] Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin
    Galeotti, Caroline
    Bayry, Jagedeesh
    Kone-Paut, Isabelle
    Kaveri, Srinivas V.
    AUTOIMMUNITY REVIEWS, 2010, 9 (06) : 441 - 448